236 related articles for article (PubMed ID: 27507852)
1. FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model.
Gstalder C; Ader I; Cuvillier O
Mol Cancer Ther; 2016 Oct; 15(10):2465-2474. PubMed ID: 27507852
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer.
Ader I; Gstalder C; Bouquerel P; Golzio M; Andrieu G; Zalvidea S; Richard S; Sabbadini RA; Malavaud B; Cuvillier O
Oncotarget; 2015 May; 6(15):13803-21. PubMed ID: 25915662
[TBL] [Abstract][Full Text] [Related]
3. A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma.
Salama MF; Carroll B; Adada M; Pulkoski-Gross M; Hannun YA; Obeid LM
FASEB J; 2015 Jul; 29(7):2803-13. PubMed ID: 25805832
[TBL] [Abstract][Full Text] [Related]
4. Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1α and HIF2α.
Schönenberger D; Harlander S; Rajski M; Jacobs RA; Lundby AK; Adlesic M; Hejhal T; Wild PJ; Lundby C; Frew IJ
Cancer Res; 2016 Apr; 76(7):2025-36. PubMed ID: 26759234
[TBL] [Abstract][Full Text] [Related]
5. STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma.
Horiguchi A; Asano T; Kuroda K; Sato A; Asakuma J; Ito K; Hayakawa M; Sumitomo M; Asano T
Br J Cancer; 2010 May; 102(11):1592-9. PubMed ID: 20461084
[TBL] [Abstract][Full Text] [Related]
6. The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway.
Beider K; Rosenberg E; Bitner H; Shimoni A; Leiba M; Koren-Michowitz M; Ribakovsky E; Klein S; Olam D; Weiss L; Wald H; Abraham M; Galun E; Peled A; Nagler A
Clin Cancer Res; 2017 Apr; 23(7):1733-1747. PubMed ID: 27697999
[No Abstract] [Full Text] [Related]
7. FTY720 enhances TRAIL-mediated apoptosis by up-regulating DR5 and down-regulating Mcl-1 in cancer cells.
Woo SM; Seo BR; Min KJ; Kwon TK
Oncotarget; 2015 May; 6(13):11614-26. PubMed ID: 25843953
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.
Li W; Li J; Wang Y; Zhang K; Li N; Tian Z; Ni B; Wang H; Ruan Z
Oncotarget; 2016 Dec; 7(49):80586-80598. PubMed ID: 27811359
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation.
McCracken AN; McMonigle RJ; Tessier J; Fransson R; Perryman MS; Chen B; Keebaugh A; Selwan E; Barr SA; Kim SM; Roy SG; Liu G; Fallegger D; Sernissi L; Brandt C; Moitessier N; Snider AJ; Clare S; Müschen M; Huwiler A; Kleinman MT; Hanessian S; Edinger AL
Leukemia; 2017 Mar; 31(3):669-677. PubMed ID: 27573555
[TBL] [Abstract][Full Text] [Related]
11. SPHK1 Is a Novel Target of Metformin in Ovarian Cancer.
Hart PC; Chiyoda T; Liu X; Weigert M; Curtis M; Chiang CY; Loth R; Lastra R; McGregor SM; Locasale JW; Lengyel E; Romero IL
Mol Cancer Res; 2019 Apr; 17(4):870-881. PubMed ID: 30655321
[TBL] [Abstract][Full Text] [Related]
12. HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma.
Qiu B; Ackerman D; Sanchez DJ; Li B; Ochocki JD; Grazioli A; Bobrovnikova-Marjon E; Diehl JA; Keith B; Simon MC
Cancer Discov; 2015 Jun; 5(6):652-67. PubMed ID: 25829424
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
Butler J; Lana D; Round O; LaMontagne K
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
[TBL] [Abstract][Full Text] [Related]
14. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
Joshi S; Singh AR; Zulcic M; Durden DL
Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer.
Katsuta E; Yan L; Nagahashi M; Raza A; Sturgill JL; Lyon DE; Rashid OM; Hait NC; Takabe K
J Surg Res; 2017 Nov; 219():202-213. PubMed ID: 29078883
[TBL] [Abstract][Full Text] [Related]
16. The role of HIF1α in renal cell carcinoma tumorigenesis.
Gudas LJ; Fu L; Minton DR; Mongan NP; Nanus DM
J Mol Med (Berl); 2014 Aug; 92(8):825-36. PubMed ID: 24916472
[TBL] [Abstract][Full Text] [Related]
17. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.
Nagahashi M; Yamada A; Katsuta E; Aoyagi T; Huang WC; Terracina KP; Hait NC; Allegood JC; Tsuchida J; Yuza K; Nakajima M; Abe M; Sakimura K; Milstien S; Wakai T; Spiegel S; Takabe K
Cancer Res; 2018 Apr; 78(7):1713-1725. PubMed ID: 29351902
[TBL] [Abstract][Full Text] [Related]
18. Molecular targets of FTY720 (fingolimod).
Pitman MR; Woodcock JM; Lopez AF; Pitson SM
Curr Mol Med; 2012 Dec; 12(10):1207-19. PubMed ID: 22834825
[TBL] [Abstract][Full Text] [Related]
19. HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell Carcinoma.
Wong SC; Cheng W; Hamilton H; Nicholas AL; Wakefield DH; Almeida A; Blokhin AV; Carlson J; Neal ZC; Subbotin V; Zhang G; Hegge J; Bertin S; Trubetskoy VS; Rozema DB; Lewis DL; Kanner SB
Mol Cancer Ther; 2018 Jan; 17(1):140-149. PubMed ID: 29079709
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
Pasupuleti V; Du W; Gupta Y; Yeh IJ; Montano M; Magi-Galuzzi C; Welford SM
J Biol Chem; 2014 Feb; 289(6):3713-23. PubMed ID: 24356968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
